The emergence of non-cytolytic NK1.1+ T cells in the long-term culture of murine tumour-infiltrating lymphocytes: A possible role of transforming growth factor-β

Immunology

Volumn 89, Issue 4, 1996, Pages 627-635

  Tamada, K ^a   Harada, M ^a   Ito, O ^a   Takenoyama, M ^a   Mori, T ^a   Matsuzaki, G ^a   Nomoto, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; LYMPHOMA; MELANOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOMA; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0029856659     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-771.x     Document Type: Article

References (53)

1. + thymocytes selected by MHC class I molecules. Science 263, 1774.
2. - single-positive thymocyte subpopulation that expresses a highly skewed T cell antigen receptor family. Proc Natl Acad Sci USA 89, 6506.
3. - 8 T cells in mice and humans. J Exp Med 180, 1097.
4. + subset. J Immunol 145, 1039.
5. + T cell populations. Int Immunol 7, 1157.
6. + cells. J Immunol 145, 3209.
7. + thymocytes. J Immunol 146, 1113.
8. + T cell antigen receptor a chain in mice. Proc Natl Sci USA 88, 7518.
9. MAKINO Y., YAMAGATA N., SASHO T. et al. (1993) Extrathymic development of Vα14-positive T cells. J Exp Med 177, 1399.
10. SATO K., OHTSUKA K., HASEGAWA K. et al. (1995) Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. J Exp Med 182, 759.
11. - thymocytes by class I molecules expressed by hematopoietic cells. J Exp Med 178, 901.
12. + thymocytes. J Exp Med 180, 395.
13. + cells in the liver of mice. J Exp Med 180, 699.
14. + T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone marrow-derived cells. Proc Natl Sci USA 92, 1200.
15. + thymocyte population associated with intact Fas antigen expression on the target. J Exp Med 180, 423.
16. + CD4 CD8 T cells produce IL-4. J Immunol 149, 1211.
17. - thymocytes with specific lymphokine secretion. Eur J Immunol 23, 307.
18. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 179, 1285.
19. YANKELEVICH B., KNOBLOCH C., NOWICKI M. & DENNERT G. (1989) A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts. J Immunol 142, 3423.
20. KIKLY K. & DENNERT G. (1992) Evidence for a role for T cell receptors (TCR) in the effector phase of acute bone marrow graft rejection. J Immunol 149, 3489.
21. ROOK A.H., KEHRL J.H., WAKEFIELD L.M. et al. (1986) Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136, 3916.
22. - large granular lymphocyte functions: regulation of IL-2Rβ (p. 75) signal transduction. J Immunol 146, 3791.
23. KEHRL J.H., WAKEFIELD L.M., ROBERTS A.B. et al. (1986) Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163, 1037.
24. FOX F.E,. FORD H.C., DOUGLAS R., CHERIAN S. & NOWELL P.C. (1993) Evidence that TGF-β can inhibit human T-lymphocytes proliferation through paracrine and autocrine mechanisms. Cell Immunol 150, 45.
25. MULE J.J., SCHWARZ S.L., ROBERTZ A.B., SPORN M.B. & ROSENBERG S.A. (1988) Transforming growth factor-β inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer Immunol Immunother 26, 95.
26. RANGES G.E., FIGARI I.S., ESPEVIK T. & PALLADINO J. (1987) Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by tumor necrosis factor α. J Exp Med 166, 991.
27. LEE H.M. & RICH S. (1991) Co-stimulation of T cell proliferation by transforming growth factor-β1. J Immunol 147, 1127.
28. WEINBERG A.D., WHITHAM R., SWAIN S.L. et al. (1992) Transforming growth factor-β enhances the in vivo effector function and memory phenotype of antigen-specific T helper cells in experimental autoimmune encephalomyelitis. J Immunol 148, 2109.
29. CERWENKA A., BEVEC D., MAJDIC O., KNAPP W. & HOLTER W. (1994) TGF-β1 is a potent inducer of human effector T cells. J Immunol 153, 4367.
30. LUCAS C., BALD L.N., FENDLY B.M. et al. (1990) The autocrine production of transforming growth factor-β1 during lymphocyte activation.: a study with a monoclonal antibody-based ELISA. J Immunol 145, 1415.
31. ROSENBERG S.A., SPIESS P. & LAFRENIERE R. (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233, 1318.
32. SPIESS P.J., YANG J.C. & ROSENBERG S.A. (1987) In vitro antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2. J Natl Cancer Inst 79, 1067.
33. ITO K., TILDEN A.B. & BAICH C.M. (1986) Interleukin-2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanoma. Cancer Res 46, 3011.
34. KURNIK J.T., KRADIN R.L., BLUMBERG R., SCHNEEBERGER E.E. & BOYLE L.A. (1986) Functional characterization of T lymphocytes propagated from human lung carcinoma. Clin Immunol Immunopathol 38, 367.
35. ROSENBERG S.A., PACKARD B.A., AEBERSOLD P.M. et al. (1988) Use of tumor infiltrating lymphocytes and interleukin 2 in the immunotherapy of patients with metastatic melanoma. N Engl J Med 319, 1676.
36. KRADIN R.L., KURNICK J.T., LAZARUS D.S. et al. (1989) Tumor infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer. Lancet 18, 577.
37. GREENBERG P.D. (1991) Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv Immunol 49, 281.
38. OKAMOTO T., HARADA M., SHINOMIYA Y., MATSUZAKI G. & NOMOTO K. (1995) The antitumor effect of tumor-draining lymph node cells activated by both anti-CD3 monoclonal antibody and activated B cells as costimulatory-signal-providing cells. Cancer Immunol Immunother 40, 173.
39. TAMADA K., HARADA M., OKAMOTO T. et al. (1995) Specific antitumor activity of tumor-infiltrating lymphocytes expanded first in a culture with both anti-CD3 monoclonal antibody and activated B cells and then in a culture with interleukin-2. Cancer Immunol Immunother 41, 339.
40. CHOMCZYNSKI P. & SACCHI N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156.
41. + CD4 CD8 T cells with a skewed variable region repertoire after infection with Listeria monocytogenes. Eur J Immunol 25 (1985).
42. + lymphokine-activated killer subset. J Immunol 150, 17.
43. - cells that make Th2 cytokines and help B cells. Science 260, 1802.
44. KOSEKI H., INAI K., ICHIKAWA T., HAYATA I. & TANIGUCHI M. (1989) Predominant use of a particular α-chain in suppressor T cell hybridomas specific for keyhole limpet hemocyanin. Int Immunol 1, 557.
45. BARBO J.V., MCCORMARK J.E., MOORHEAD J.W. & FAIRCHILD R.J. (1995) Reconstitution of TCR α-chain expression in deletion mutants restores dinitrophenyl-specific/class I MHC-restricted suppressor molecule production. J Immunol 154, 1551.
46. PALATHUMPAT V., DEJBAKHSH-JONES S., HOLM B. & STROBER S. (1992) Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-vs.-host disease. J Immunol 149, 808.
47. + T lymphocytes. Science 268, 863.
48. BELLONE G., ASTE-AMEZAGA M., TRINCHIERI G. & RODECK U. (1995) Regulation of NK cell functions by TGF-β. J Immunol 155, 1066.
49. + T cells and NK cells. J Exp Med 180 (1937).
50. + T cells. J Immunol 155, 609.
51. ZHANG X., GIANGRECO L., BROOME H.E., DARGAN C.M. & SWAIN S.L. (1995) Control of CD4 effector fate: transforming growth factor β1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J Exp Med 182, 699.
52. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 154, 4333.
53. D'ANDREA A., RENGARAJU M., VALIANTE N.M. et al. (1992) Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176, 1387.